Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.
about
SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humansRecent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesPrimate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.Improvement of antibody responses by HIV envelope DNA and protein co-immunization.Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.Conserved HIV Epitopes for an Effective HIV Vaccine.
P2860
Q27014903-34C4CB18-40F9-413A-BF3E-0F3144240856Q30353580-BB114FEF-7967-405A-9731-83DBCE3785C2Q34133551-3D29F900-0549-4ABA-BD04-38E390B16428Q34230556-9ECB389C-73E2-4898-9E09-56FF1DD48298Q35032794-95053554-D433-483A-903C-C080D2ACBEC7Q35169535-446E3AD0-6CEE-4EF2-99D5-3C5FD839A094Q35914362-708D7AEC-61AF-495E-AD4A-EA0ABD350DC9Q36694841-527502B4-6656-4D11-8594-65BCF21DD2E4Q36754331-01E8C9E1-9C46-4189-9FEF-E8E146E12BCCQ37336704-76D7F980-3C58-4946-8B0A-836E37F6E0BBQ37588371-8F3299F5-3C34-4C10-8CEE-A6DE7EA3930CQ38541824-DF8842DE-7437-4755-8D50-7B5A18AEFA1DQ41829933-AC072FC4-FE35-485E-B6CE-808EBDAAF411Q47093684-D62E1488-48BE-41B6-B1D9-128B3C0E05B3
P2860
Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunization with wild-type or ...... -human immunodeficiency virus.
@ast
Immunization with wild-type or ...... -human immunodeficiency virus.
@en
Immunization with wild-type or ...... -human immunodeficiency virus.
@nl
type
label
Immunization with wild-type or ...... -human immunodeficiency virus.
@ast
Immunization with wild-type or ...... -human immunodeficiency virus.
@en
Immunization with wild-type or ...... -human immunodeficiency virus.
@nl
prefLabel
Immunization with wild-type or ...... -human immunodeficiency virus.
@ast
Immunization with wild-type or ...... -human immunodeficiency virus.
@en
Immunization with wild-type or ...... -human immunodeficiency virus.
@nl
P2093
P2860
P356
P1433
P1476
Immunization with wild-type or ...... -human immunodeficiency virus.
@en
P2093
Andreas Mörner
Gunilla B Karlsson Hedestam
Iyadh Douagi
Karin Loré
Mattias N Forsell
Richard T Wyatt
Sijy O'Dell
P2860
P304
P356
10.1128/JVI.01015-10
P407
P577
2010-07-07T00:00:00Z